Skip to Main content Skip to Navigation
Journal articles

Platelet-activating factor and normal or leukaemic haematopoiesis.

Abstract : Platelet-activating factor (PAF), a phospholipid mediator with a wide range of actions on mature leukocytes, acts directly during early human haematopoiesis by affecting the growth of haematopoietic progenitors and indirectly, by modulating cytokine synthesis by bone marrow stromal cells. At this time, its role during leukaemic diseases remains speculative. The lack of membrane PAF receptor (PAF-R) on leukaemic blasts suggest that this receptor represents a marker of mature cells and its membrane induction a consequence of cell maturation. While the couple PAF/PAF-R has been largely studied using B cell lines, few results are available using B cells of patients with haematopoietic malignancies casting some doubts concerning the potential role (if any) of this molecule during leukaemic diseases.
Document type :
Journal articles
Complete list of metadata
Contributor : Claire Carrion Connect in order to contact the contributor
Submitted on : Friday, April 28, 2006 - 1:57:29 PM
Last modification on : Wednesday, October 20, 2021 - 1:31:04 AM





Yves Denizot, Laurence Guglielmi, Magali Donnard, Franck Trimoreau. Platelet-activating factor and normal or leukaemic haematopoiesis.. Leukemia & lymphoma, Taylor & Francis, 2003, 44 (5), pp.775-82. ⟨10.1080/1042819031000067549⟩. ⟨hal-00023532⟩



Record views